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Performance-based payment schemes are nothing new
for not-for-profit organizations that use commercial busi-
ness models, such as social marketing and social fran-
chise programs. Perhaps because of their familiarity with
using output-based budgeting processes, these programs
have advanced the development of different types of
modeling techniques for describing impacts on health
outcomes, and applied these estimates to monitor pro-
grams worldwide. Tried and true estimates of health sta-
tus have been used in new ways, and innovative estimates
of equity are reported. Each of these developments is dis-
cussed in this special supplement, and each has some-
thing to say about the metrics that are used, and the
usefulness of the results they produce.
The disability-adjusted life year metric (DALY) is a well-
known measure of a population’s disease burden, most
commonly known for its use in estimating the global bur-
den of disease. The construction of the DALY statistic has
not been without controversy, particularly the relative
valuation of some interventions over others and the speci-
fication of the weights that are assigned for the measure-
ment of health losses. The Global Burden of Disease Study
2010 provided fresh re-estimations of these weights using
large-scale, population-based data sources, representing a
major advancement with the DALY metric [1,2]. The var-
iation of the DALY metric to suggest the effectiveness of
programs, the DALYs averted metric, is an attractive theo-
retical premise that several of the papers in this special
supplement explore. Through the use of large-scale pro-
gram performance data across multiple countries, these
papers carefully develop original applications of the
DALYs averted metric, tracking impact of a single pro-
gram, and comparing programs across widely different set-
tings. In the process, several interesting issues arise that
are surely causing conundrums for managers. For exam-
ple, the shift from counting the number of products sold
to estimating health impact showed that it is the level of
disease prevalence (and mortality rates) that will drive the
DALYs averted count; smaller programs in high disease
burden settings have a larger impact in terms of DALYs
averted than large programs in settings with low disease
prevalence [3,4].
There are a number of conceptual leaps made in the
models being reported, particularly as they move from
using products and service utilization statistics to estimat-
ing the numbers of DALYs averted based upon the pre-
dicted impact of behavior change interventions. The
application of these analytic methods across a wide range
of services and products within the framework of routine
monitoring are innovative achievements, and represent
advances to the field of measuring health impact. How-
ever, underlying the models are the ubiquitous problems
with data quality - even in closely managed social market-
ing and franchise programs. The broader use of modeling
DALYs averted counts will be challenging in settings
where the availability of reliable and valid data has been a
constraint to capturing accurate measures of performance.
The modeling of DALYs averted is a leap in analytic
sophistication for programs accustomed to reporting tal-
lies of outputs, as well as more standard rates or ratios as
measures of coverage and impact. The requisite skills in
complex statistical modeling will be a constraint to the
wide-scale diffusion of the DALYs averted technique for
monitoring impact.
An alternative approach to measuring a program’s
impact is to assess its contribution to national health goals,
rather than suggest attribution to changes in population
health status. Family planning programs are assessed on an
aggregate level by changes in the population’s contraceptive
prevalence and on a programmatic level by couple-years of
protection (CYPs). CYPs convert the number of contracep-
tives distributed into numbers of contraceptive users. The
Marie Stopes International Impact 2 model goes the next
step by using an innovative technique that estimates a ser-
vice delivery organization’s marginal contribution to popu-
lation-level contraceptive prevalence rates (CPR) that is
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made by the number of contraceptive users served (which
is derived from the number of products distributed). It is
quite a stretch, but the analysis is elegant and the solutions
to working around substitution effects are innovative,
despite the several underlying assumptions and limitations
imposed by the type of data that is used. The results are
immediately relevant for national health policy and contri-
bute to making the case for public-private partnership in
achieving national health goals. In general, our understand-
ing of the private health sector’s expansion far outweighs
information about its actual contribution to achieving
national health goals. In part, this can be attributed to
weak incentives for private sector networks to report utili-
zation statistics to government. Increased understanding of
the relative contribution made by private sector organiza-
tions will facilitate government regulatory oversight and
strengthen public-private partnership linkages. The analytic
approach discussed in this supplement is a step in the right
direction - let’s look for more such evidence as large-scale,
not-for-profit programs continue to mature in their opera-
tions and relations with government.
Programs that are designed to reach the poor with
subsidized services have historically experienced crowd-
ing out by the less poor, who are better able to over-
come non-financial barriers to access. Ensuring that
target populations are reached is an important function
of impact metrics, particularly for social marketing and
social franchise programs. Wealth quintiles have been
an easily recognized and interpretable metric of equity.
The concentration index is another measure that has
the benefit of being comparable across different settings
and times, as well as the drawback of being somewhat
difficult to interpret. Additionally, the concentration
index is comparable only to itself, thereby making it less
useful in sectoral policy dialogue. A practical solution
presented in in this supplement by Chakraborty et al.
combines the two metrics and incorporates a national
reference population for comparative analyses [5]. The
results showed that social marketing programs were
reaching groups that were wealthier than the national
samples, tending towards the higher quintiles rather
than the poorer. This challenges the notion that social
marketing programs reach a different group than com-
mercial marketing. As this finding goes to the heart of a
basic strategy behind the social marketing concept,
further evidence is needed to determine if the crowding
out phenomenon is taking place and, if so, why. The
bottom-line indicator should not be lost in this discus-
sion, however: Does the social marketing program
increase utilization or does it simply cause a shift in
sources of care among those who are presently covered
by the national health program? Government may be
more effective in reaching the poor, and the private sec-
tor more effective in growing coverage among the near
poor and middle class. This is not necessarily the strat-
egy of social marketing programs, but it would resonate
in many policy discussions.
Taken as a whole, the papers in this special issue con-
vey insights into the extensive monitoring and evalua-
tion of two of the large, not-for-profit global health
programs. Substantial resources are being used to con-
vert the measures of services delivered and commercial
products sold or distributed that were being routinely
collected by social marketing and social franchise pro-
grams as output metrics into something more multi-
dimensional to suggest impact. This is nicely done with
rigor and sophistication. Where gaps exist between the
data and theory, informed assumptions are made,
proxies are used, and data are run through the models.
This modeling should encourage other service delivery
organizations to move beyond performance measures
and to create models of impact. Strategic decisions on
how to assess impact will need to be made, however,
balancing investments in upgrading analytic capacity
using routinely collected statistics versus mounting spe-
cial studies that utilize primary data collection methods.
Final decisions on how any given program, or organiza-
tion can best report on its impact will depend on a mix
of factors. The importance of moving beyond measures
of performance to impact is well understood and, as the
papers in this special edition reveal, innovative techni-
ques are being developed to respond to the simple ques-
tion, “Are we making a difference?”
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